JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, vol.9, no.3, pp.309-312, 2015 (SCI-Expanded)
Introduction: The widespread use of tigecycline raises the question of increasing infection rates of Pseudomonas aeruginosa (PA) in ICUs which are not affected by this antibiotic.